Clinical Trial of Ventiflow LP Supporting High-risk Percutaneous Coronary Intervention(PCI)

NANot yet recruitingINTERVENTIONAL

Enrollment

250

Participants

Timeline

Start Date

December 31, 2024

Primary Completion Date

October 31, 2025

Study Completion Date

December 31, 2025

Conditions

Coronary Artery DiseaseHeart FailureHigh-risk PCI

Interventions

DEVICE

Percutaneous left ventricular assist device(Ventiflow LP)

The PCI will be completed with the support of percutaneous left ventricular assist device(Ventiflow LP).

DEVICE

VA-ECMO

The PCI will be completed with the support of Veno-arterial extracorporeal membrane oxygenation (VA-ECMO).

All Listed Sponsors

lead

Suzhou Hearthill Medical Technology Co.,LTD

INDUSTRY

NCT06754839 - Clinical Trial of Ventiflow LP Supporting High-risk Percutaneous Coronary Intervention(PCI) | Biotech Hunter | Biotech Hunter